TY - JOUR TI - EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma AU - Fang, Runping AU - Chen, Xin AU - Zhang, Sicong AU - Shi, Hui AU - Ye, Youqiong AU - Shi, Hailing AU - Zou, Zhongyu AU - Li, Peng AU - Guo, Qing AU - Ma, Li AU - He, Chuan AU - Huang, Suyun T2 - Nature Communications AB - Glioblastoma (GBM) is the most common type of adult malignant brain tumor, but its molecular mechanisms are not well understood. In addition, the knowledge of the disease-associated expression and function of YTHDF2 remains very limited. Here, we show that YTHDF2 overexpression clinically correlates with poor glioma patient prognosis. EGFR that is constitutively activated in the majority of GBM causes YTHDF2 overexpression through the EGFR/SRC/ERK pathway. EGFR/SRC/ERK signaling phosphorylates YTHDF2 serine39 and threonine381, thereby stabilizes YTHDF2 protein. YTHDF2 is required for GBM cell proliferation, invasion, and tumorigenesis. YTHDF2 facilitates m6A-dependent mRNA decay of LXRA and HIVEP2, which impacts the glioma patient survival. YTHDF2 promotes tumorigenesis of GBM cells, largely through the downregulation of LXRα and HIVEP2. Furthermore, YTHDF2 inhibits LXRα-dependent cholesterol homeostasis in GBM cells. Together, our findings extend the landscape of EGFR downstream circuit, uncover the function of YTHDF2 in GBM tumorigenesis, and highlight an essential role of RNA m6A methylation in cholesterol homeostasis. DA - 2021/01/08/ PY - 2021 DO - 10.1038/s41467-020-20379-7 DP - www.nature.com VL - 12 IS - 1 SP - 177 LA - en SN - 2041-1723 UR - https://www.nature.com/articles/s41467-020-20379-7 Y2 - 2021/01/08/19:04:34 ER -